Clinical trial
A Two-stage 6-month Multicentre, Randomised, Double-blind, Controlled Study on the Safety and Efficacy Intra-articular Administration of JTA-004 in Patients With Symptomatic Knee Osteoarthritis
NCT02740231 is registered in ClinicalTrials.gov with Bone Therapeutics S.A as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Two-stage 6-month Multicentre, Randomised, Double-blind, Controlled Study on the Safety and Efficacy Intra-articular Administration of JTA-004 in Patients With Symptomatic Knee Osteoarthritis
- Lead sponsor
- Bone Therapeutics S.A
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- February 29, 2016
- Completion date
- April 27, 2018
- Enrollment
- 173 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
knee osteoarthritis